Wootton M - Search Results

1

Ventriculitis due to a hetero strain of vancomycin intermediate Staphylococcus aureus (hVISA): successful treatment with linezolid in combination with intraventricular vancomycin.

Amod F, Moodley I, Peer AK, Sunderland J, Lovering A, Wootton M, Nadvi S, Vawda F. Amod F, et al. Among authors: wootton m. J Infect. 2005 Apr;50(3):252-7. doi: 10.1016/j.jinf.2004.04.002. J Infect. 2005. PMID: 15780422

2

Evaluation of the effectiveness of common hospital hand disinfectants against methicillin-resistant Staphylococcus aureus, glycopeptide-intermediate S. aureus, and heterogeneous glycopeptide-intermediate S. aureus.

Wootton M, Walsh TR, Davies EM, Howe RA. Wootton M, et al. Infect Control Hosp Epidemiol. 2009 Mar;30(3):226-32. doi: 10.1086/595691. Infect Control Hosp Epidemiol. 2009. PMID: 19199533

3

Activity of AZD2563, a novel oxazolidinone, against Staphylococcus aureus strains with reduced susceptibility to vancomycin or linezolid.

Howe RA, Wootton M, Noel AR, Bowker KE, Walsh TR, MacGowan AP. Howe RA, et al. Among authors: wootton m. Antimicrob Agents Chemother. 2003 Nov;47(11):3651-2. doi: 10.1128/AAC.47.11.3651-3652.2003. Antimicrob Agents Chemother. 2003. PMID: 14576139 Free PMC article.

4

A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital.

Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP. Wootton M, et al. J Antimicrob Chemother. 2001 Apr;47(4):399-403. doi: 10.1093/jac/47.4.399. J Antimicrob Chemother. 2001. PMID: 11266410

5

Staphylococcus aureus with reduced glycopeptide susceptibility in Liverpool, UK.

Kirby A, Graham R, Williams NJ, Wootton M, Broughton CM, Alanazi M, Anson J, Neal TJ, Parry CM. Kirby A, et al. Among authors: wootton m. J Antimicrob Chemother. 2010 Apr;65(4):721-4. doi: 10.1093/jac/dkq009. Epub 2010 Feb 2. J Antimicrob Chemother. 2010. PMID: 20124288

6

The activity of vancomycin against heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus explored using an in vitro pharmacokinetic model.

Turner J, Howe RA, Wootton M, Bowker KE, Holt HA, Salisbury V, Bennett PM, Walsh TR, MacGowan AP. Turner J, et al. Among authors: wootton m. J Antimicrob Chemother. 2001 Nov;48(5):727-30. doi: 10.1093/jac/48.5.727. J Antimicrob Chemother. 2001. PMID: 11679564

7

Expression and detection of hetero-vancomycin resistance in Staphylococcus aureus.

Howe RA, Wootton M, Walsh TR, Bennett PM, MacGowan AP. Howe RA, et al. Among authors: wootton m. J Antimicrob Chemother. 1999 Nov;44(5):675-8. doi: 10.1093/jac/44.5.675. J Antimicrob Chemother. 1999. PMID: 10552985

8

A multicenter study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides.

Wootton M, MacGowan AP, Walsh TR, Howe RA. Wootton M, et al. J Clin Microbiol. 2007 Feb;45(2):329-32. doi: 10.1128/JCM.01508-06. Epub 2006 Nov 15. J Clin Microbiol. 2007. PMID: 17108069 Free PMC article.

9

Heterogeneous resistance to vancomycin in Staphylococcus aureus.

Howe RA, Wootton M, Walsh TR, Bennett PM, Macgowan AP. Howe RA, et al. Among authors: wootton m. J Antimicrob Chemother. 2000 Jan;45(1):130-2. doi: 10.1093/jac/45.1.130. J Antimicrob Chemother. 2000. PMID: 10629026 No abstract available.

10

Interactions between methicillin and vancomycin in methicillin-resistant Staphylococcus aureus strains displaying different phenotypes of vancomycin susceptibility.

Howe RA, Wootton M, Bennett PM, MacGowan AP, Walsh TR. Howe RA, et al. Among authors: wootton m. J Clin Microbiol. 1999 Sep;37(9):3068-71. doi: 10.1128/JCM.37.9.3068-3071.1999. J Clin Microbiol. 1999. PMID: 10449511 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page